These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 16734519)

  • 1. Metal homeostasis in Alzheimer's disease.
    White AR; Barnham KJ; Bush AI
    Expert Rev Neurother; 2006 May; 6(5):711-22. PubMed ID: 16734519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic treatments for Alzheimer's disease based on metal bioavailability.
    Crouch PJ; Barnham KJ; Bush AI; White AR
    Drug News Perspect; 2006 Oct; 19(8):469-74. PubMed ID: 17160147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The modulation of metal bio-availability as a therapeutic strategy for the treatment of Alzheimer's disease.
    Crouch PJ; White AR; Bush AI
    FEBS J; 2007 Aug; 274(15):3775-83. PubMed ID: 17617225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alzheimer's disease, metal ions and metal homeostatic therapy.
    Zatta P; Drago D; Bolognin S; Sensi SL
    Trends Pharmacol Sci; 2009 Jul; 30(7):346-55. PubMed ID: 19540003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic treatment of Alzheimer's disease using metal complexing agents.
    Price KA; Crouch PJ; White AR
    Recent Pat CNS Drug Discov; 2007 Nov; 2(3):180-7. PubMed ID: 18221229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metal exposure and Alzheimer's pathogenesis.
    Liu G; Huang W; Moir RD; Vanderburg CR; Lai B; Peng Z; Tanzi RE; Rogers JT; Huang X
    J Struct Biol; 2006 Jul; 155(1):45-51. PubMed ID: 16503166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological metals and Alzheimer's disease: implications for therapeutics and diagnostics.
    Duce JA; Bush AI
    Prog Neurobiol; 2010 Sep; 92(1):1-18. PubMed ID: 20444428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clioquinol inhibits peroxide-mediated toxicity through up-regulation of phosphoinositol-3-kinase and inhibition of p53 activity.
    Filiz G; Caragounis A; Bica L; Du T; Masters CL; Crouch PJ; White AR
    Int J Biochem Cell Biol; 2008; 40(5):1030-42. PubMed ID: 18160328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elucidating the role of metals in Alzheimer's disease through the use of Surface-Enhanced Laser Desorption/Ionisation time-of-flight mass spectrometry.
    Watt AD; Perez KA; Hung LW
    Methods Mol Biol; 2011; 752():229-40. PubMed ID: 21713641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium dysregulation in Alzheimer's disease.
    Bojarski L; Herms J; Kuznicki J
    Neurochem Int; 2008; 52(4-5):621-33. PubMed ID: 18035450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The missing link in the amyloid cascade of Alzheimer's disease - metal ions.
    Tiiman A; Palumaa P; Tõugu V
    Neurochem Int; 2013 Mar; 62(4):367-78. PubMed ID: 23395747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mapping cellular transcriptosomes in autopsied Alzheimer's disease subjects and relevant animal models.
    Reddy PH; McWeeney S
    Neurobiol Aging; 2006 Aug; 27(8):1060-77. PubMed ID: 16157420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapy of Alzheimer disease].
    Kovács T
    Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular pathology and pharmacogenomics in Alzheimer's disease: polygenic-related effects of multifactorial treatments on cognition, anxiety and depression.
    Cacabelos R
    Methods Find Exp Clin Pharmacol; 2007 Jul; 29 Suppl A():1-91. PubMed ID: 17957277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling behavioral and neuronal symptoms of Alzheimer's disease in mice: a role for intraneuronal amyloid.
    Giménez-Llort L; Blázquez G; Cañete T; Johansson B; Oddo S; Tobeña A; LaFerla FM; Fernández-Teruel A
    Neurosci Biobehav Rev; 2007; 31(1):125-47. PubMed ID: 17055579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metal-associated amyloid-β species in Alzheimer's disease.
    Pithadia AS; Lim MH
    Curr Opin Chem Biol; 2012 Apr; 16(1-2):67-73. PubMed ID: 22366383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium dyshomeostasis and neurotoxicity of Alzheimer's beta-amyloid protein.
    Kawahara M; Negishi-Kato M; Sadakane Y
    Expert Rev Neurother; 2009 May; 9(5):681-93. PubMed ID: 19402778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathophysiology of neuronal energy crisis in Alzheimer's disease.
    de la Torre JC
    Neurodegener Dis; 2008; 5(3-4):126-32. PubMed ID: 18322369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metallo-complex activation of neuroprotective signalling pathways as a therapeutic treatment for Alzheimer's disease.
    Bica L; Crouch PJ; Cappai R; White AR
    Mol Biosyst; 2009 Feb; 5(2):134-42. PubMed ID: 19156258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukins, inflammation, and mechanisms of Alzheimer's disease.
    Weisman D; Hakimian E; Ho GJ
    Vitam Horm; 2006; 74():505-30. PubMed ID: 17027528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.